Founded Year
1999Stage
Spinoff / Spinout | AliveAbout Frio Pharmaceuticals
Frio Pharmaceuticals is dedicated to oral-systemic health and was spun out of Biomedical Development Corporation (BDC), its research affiliate, in 1999 to manufacture and sell a dental waterline cleaner. This platform technology has evolved into a pipeline of pharmaceuticals to treat oral diseases and interrupt the disease process. Its goal is to commercialize a broad-spectrum antimicrobial platform technology with products being: (1) a pharmaceutical to treat thrush (oral candidiasis) in cancer patients with thrush and (2) a pharmaceutical to treat gingivitis (oral inflammation).
Loading...
Loading...
Frio Pharmaceuticals Frequently Asked Questions (FAQ)
When was Frio Pharmaceuticals founded?
Frio Pharmaceuticals was founded in 1999.
Where is Frio Pharmaceuticals's headquarters?
Frio Pharmaceuticals's headquarters is located at San Antonio.
What is Frio Pharmaceuticals's latest funding round?
Frio Pharmaceuticals's latest funding round is Spinoff / Spinout.
Who are the investors of Frio Pharmaceuticals?
Investors of Frio Pharmaceuticals include Biomedical Development and SATAI Network.
Who are Frio Pharmaceuticals's competitors?
Competitors of Frio Pharmaceuticals include Cornerstone Pharmaceuticals, Aquinox Pharmaceuticals, Acura Pharmaceuticals, Diffusion Pharmaceuticals, TARIS Biomedical - LiRIS and 7 more.
Loading...
Compare Frio Pharmaceuticals to Competitors
ISA Pharmaceuticals is a company focused on the development of immunotherapeutics in the healthcare and biotechnology industry. The company's main offerings include the creation of synthetic immunotherapeutics designed to harness and direct the body's own defenses to fight against cancer and persistent viral infections. ISA Pharmaceuticals primarily serves the healthcare industry. It was founded in 2004 and is based in Oegstgeest, Netherlands.
Banyan Biomarkers is a company focused on the discovery, validation, and commercialization of biochemical markers in the healthcare sector. The company's main service is the development of a blood test that aids in the evaluation of concussions, potentially eliminating the need for CT scans in patients with suspected mild traumatic brain injury. The company primarily serves the healthcare industry, particularly in the area of traumatic brain injury diagnosis. It was founded in 2013 and is based in San Diego, California.
CoImmune is a company that focuses on the development and manufacture of cell-based therapeutics, operating within the healthcare and biotechnology sectors. The company's main offerings include treatments for unmet medical needs such as cancer, autoimmune, and inflammatory diseases. It was founded in 1997 and is based in Durham, North Carolina. CoImmune operates as a subsidiary of Genexine and SCM Lifescience.
Piedmont is a specialty pharmaceutical company focused on human and animal health therapeutics with expertise in parasitology and drug delivery systems.
R&D of anti-HIV drug
Urigen Pharmaceuticals focuses on the development and commercialization of innovative products for urological indications within the healthcare sector. The company specializes in creating treatments aimed at alleviating the causes and symptoms of urological ailments, particularly Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS). It is based in North Brunswick, New Jersey.
Loading...